1hfm: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Theoretical_model}}
{{Theoretical_model}}
{{Seed}}
[[Image:1hfm.png|left|200px]]


<!--
==A THREE-DIMENSIONAL MODEL OF AN ANTI-LYSOZYME ANTIBODY==
The line below this paragraph, containing "STRUCTURE_1hfm", creates the "Structure Box" on the page.
<StructureSection load='1hfm' size='340' side='right'caption='[[1hfm]]' scene=''>
You may change the PDB parameter (which sets the PDB file loaded into the applet)  
== Structural highlights ==
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
<table><tr><td colspan='2'>For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1HFM FirstGlance]. <br>
or leave the SCENE parameter empty for the default display.
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1hfm FirstGlance], [https://www.ebi.ac.uk/pdbsum/1hfm PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1hfm ProSAT]</span></td></tr>
-->
</table>
{{STRUCTURE_1hfm|  PDB=1hfm  |  SCENE=  }}
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The primary amino acid structure of the lysozyme-binding antibody, HyHEL-10, as determined by amino acid and nucleotide sequencing was utilized to construct a scale model of the Fv (variable region domain of immunoglobulin) using energy-minimized torsional angles of the McPC603 Fv as a prototype template. This model was in turn used as a template for generating a computer-built set of co-ordinates, which were subjected to a total of 600 steps of Adopted Basis Newton-Raphson energy minimizations using the program CHARMM. Only minimal shifts of the backbone (root-mean-square 0.76 A) were required to give an energetically stable structure with a favorable van der Waals' energy. Several notable features were evident from both the scale model and the energy-minimized computer model: (1) the shape of the antibody combining region is that of a very shallow concavity approximately 20 A X 25 A; (2) the concavity is acidic and non-hydrophobic and is bordered by hydrophobic segments; (3) the lower portion of the combining site is dominated by a cluster of tyrosine residues over the L3 and H2 areas; (4) a somatic mutation encoded by the J region of the heavy chain (JH) may contribute significantly to the complementarity of heavy chain H3 to the epitope on hen egg white lysozyme. In addition, the space-filling energy-minimized model revealed that residue 49L, a framework residue, was prominently exposed and accessible in the center of the combining-site concavity. The model suggests that variation in length of complementarity-determining regions may function not only to change directly the shape of the antibody combining site, but may also influence indirectly the nature of the antibody surface by changing the accessibility of residues not usually involved in antigen binding.


===A THREE-DIMENSIONAL MODEL OF AN ANTI-LYSOZYME ANTIBODY===
A three-dimensional model of an anti-lysozyme antibody.,Smith-Gill SJ, Mainhart C, Lavoie TB, Feldmann RJ, Drohan W, Brooks BR J Mol Biol. 1987 Apr 20;194(4):713-24. PMID:3656404<ref>PMID:3656404</ref>


 
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
<!--
</div>
The line below this paragraph, {{ABSTRACT_PUBMED_3656404}}, adds the Publication Abstract to the page
<div class="pdbe-citations 1hfm" style="background-color:#fffaf0;"></div>
(as it appears on PubMed at http://www.pubmed.gov), where 3656404 is the PubMed ID number.
== References ==
-->
<references/>
{{ABSTRACT_PUBMED_3656404}}
__TOC__
 
</StructureSection>
==About this Structure==
[[Category: Theoretical Model]]
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HFM OCA].
[[Category: Large Structures]]
 
==Reference==
<ref group="xtra">PMID:3656404</ref><references group="xtra"/>
[[Category: Brooks, B R]]
[[Category: Brooks, B R]]
[[Category: Drohan, W]]
[[Category: Drohan, W]]
Line 31: Line 28:
[[Category: Mainhart, C]]
[[Category: Mainhart, C]]
[[Category: Smith-Gill, S J]]
[[Category: Smith-Gill, S J]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Apr  8 08:29:05 2010''

Latest revision as of 13:49, 4 August 2021

Theoretical Model: The protein structure described on this page was determined theoretically, and hence should be interpreted with caution.

A THREE-DIMENSIONAL MODEL OF AN ANTI-LYSOZYME ANTIBODYA THREE-DIMENSIONAL MODEL OF AN ANTI-LYSOZYME ANTIBODY

Structural highlights

For a guided tour on the structure components use FirstGlance.
Resources:FirstGlance, PDBsum, ProSAT

Publication Abstract from PubMed

The primary amino acid structure of the lysozyme-binding antibody, HyHEL-10, as determined by amino acid and nucleotide sequencing was utilized to construct a scale model of the Fv (variable region domain of immunoglobulin) using energy-minimized torsional angles of the McPC603 Fv as a prototype template. This model was in turn used as a template for generating a computer-built set of co-ordinates, which were subjected to a total of 600 steps of Adopted Basis Newton-Raphson energy minimizations using the program CHARMM. Only minimal shifts of the backbone (root-mean-square 0.76 A) were required to give an energetically stable structure with a favorable van der Waals' energy. Several notable features were evident from both the scale model and the energy-minimized computer model: (1) the shape of the antibody combining region is that of a very shallow concavity approximately 20 A X 25 A; (2) the concavity is acidic and non-hydrophobic and is bordered by hydrophobic segments; (3) the lower portion of the combining site is dominated by a cluster of tyrosine residues over the L3 and H2 areas; (4) a somatic mutation encoded by the J region of the heavy chain (JH) may contribute significantly to the complementarity of heavy chain H3 to the epitope on hen egg white lysozyme. In addition, the space-filling energy-minimized model revealed that residue 49L, a framework residue, was prominently exposed and accessible in the center of the combining-site concavity. The model suggests that variation in length of complementarity-determining regions may function not only to change directly the shape of the antibody combining site, but may also influence indirectly the nature of the antibody surface by changing the accessibility of residues not usually involved in antigen binding.

A three-dimensional model of an anti-lysozyme antibody.,Smith-Gill SJ, Mainhart C, Lavoie TB, Feldmann RJ, Drohan W, Brooks BR J Mol Biol. 1987 Apr 20;194(4):713-24. PMID:3656404[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

  1. Smith-Gill SJ, Mainhart C, Lavoie TB, Feldmann RJ, Drohan W, Brooks BR. A three-dimensional model of an anti-lysozyme antibody. J Mol Biol. 1987 Apr 20;194(4):713-24. PMID:3656404
Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA